Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 9 Pain 8 Pain, Postoperative 5 Breast Neoplasms 5 Depression 4 Agnosia 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain, Intractable 2 Chronic Pain 2 Acute Pain 2 Prostatic Neoplasms 1 Postoperative Analgesia 1 Peripheral Nervous System Diseases 1 Pelvic Neoplasms 1 Pancreatic Neoplasms 1 Neurotoxicity Syndromes 1 Neuralgia 1 Mucositis 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Hypoxia 1 Head and Neck Neoplasms 1 Emergence Delirium 1 Depressive Disorder, Major 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangitis 1 Cancer Pain 1

Interventions

Escitalopram 2 Transcranial Magnetic Stimulation 1 Sugars 1 Saline Solution 1 Mirtazapine 1 Magnetic Resonance Spectroscopy 1 Ketamine 1 Interpersonal Psychotherapy 1 Infliximab 1 Diagnostic Imaging 1 Cognitive Behavioral Therapy 1 Citalopram 1 Bupropion 1 Antidepressive Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Depressive Disorder, Major × Ketamine × Clear all

NCT04471818 2023-09-28

KODIAC

Instituto Nacional de Cancerologia de Mexico

Phase 1/2 Completed

Depressive Disorder, Major

Data powered by HemOnc (CC BY 4.0) Colophon ⚡